PODCAST-Lessons learned from the US life sciences market

While the entire life sciences industry continues to grow and evolve at a rapid pace, the COVID-19 pandemic seems to have accelerated the commercial real estate sector of the industry even more. Prior to the pandemic, the life sciences industry in the US was already on a trajectory of a growth and discovery with record-breaking venture capital and stable federal funding. When COVID-19 hit and federal funding was deployed not just toward basic research but also toward commercialization efforts, more and more companies began seeking commercial real estate space. So, where is the industry headed?

Listen as Travis McCready, Executive Director for US Life Sciences Markets at JLL sits down with Dr. Glenn Crocker, Head of Life Sciences in the UK at JLL to discuss the life sciences market in the United States and the impact that the COVID-19 pandemic has had on the industry.